Boston Scientific

Open: 57.9 Close: 57.6 Change: -0.3

You don't have time to read all about Boston Scientific Stock. An AI summarizes all the information for you.

This document will help you to evaluate Boston Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, trial, AVANT, GUARD, clinical, FARAPULSE, …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Boston Scientific has commenced the AVANT GUARD clinical trial of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line treatment for persistent atrial fibrillation. TheStreet raised shares of Boston Scientific from a “c+” rating to a ‘b-’ rating.

Today's News

Boston Scientific has commenced the AVANT GUARD clinical trial of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line treatment for persistent atrial fibrillation. Boston Scientific bought Farapulse for nearly $300 million in 2021. The new trial from Marlborough, Massachusetts-based Boston. Boston Scientific is proud to be an equal opportunity and affirmative action employer. The average employee at Boston Scientific makes $60,291 per year. Boston Scientific is an industry leader with 36,000 employees and an annual revenue of $12.0B that is headquartered in Marlborough, MA. The average employee at Boston Scientific makes $60,291 per year. Boston Scientific generates $12.7B in revenue. TheStreet raised shares of Boston Scientific from a “c+” rating to a ‘b-’ rating. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. Boston Scientific has commenced the AVANT GUARD clinical trial of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line treatment for persistent atrial fibrillation. Boston Scientific completed enrollment in the first phase of the ADVANTAGE AF clinical trial in the third quarter of 2023. Boston Scientific has chosen a Spanish project to advance its decarbonisation strategy. Medical device maker Boston Scientific topped Wall Street expectations for third-quarter profit on Thursday. The company reported revenue of $3.5 billion and adjusted earnings of $0.50 per share. Boston Scientific pulls forward expected approval for Farapulse PFA system. Analysts said a first quarter approval would increase their confidence in the companys potential for sales growth of 10%. Tumor Embolization Devices Market Size, Share And Growth Analysis For 2024-2033 Jan 2, 2024 News Provided By CB Insights Intelligence Analysts have mentioned Boston Scientific in 2 CB Inights research briefs , most recently on Jan 27, 2023. Raymond James Adjusts Price Target on Boston Scientific to $67 From $61, Maintains Strong Buy Rating Jan. 03 Raymond James. Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation.

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

How much time have you spent trying to decide whether investing in Boston Scientific? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, trial, AVANT, GUARD, clinical, FARAPULSE, and the most common words in the summary are: boston, scientific, job, stock, medical, see, company, . One of the sentences in the summary was: TheStreet raised shares of Boston Scientific from a “c+” rating to a ‘b-’ rating.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #job #stock #medical #see #company.